Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures (0.21%), Hang Seng Futures +2.07%, ASX SPI 200 +0.04%, S&P Futures +0.20%

Jan 23 ,2024

  • Synopsis:

    • Asia equities poised to open mostly higher Wednesday. Futures in Hong Kong and Australia traded firmer while Japan extended weakness from yesterday's fade. US futures extending gains in S&P 500 and Nasdaq after both indexes closed at new highs. Tech leads positive with Nasdaq outperformance, gains in SOX while Golden Dragon China index rallied in the wake of China market support headlines. Treasuries were mixed with curve steepening. Dollar index was up 0.3% with greenback stronger on the major crosses. Gold finished up 0.2%. Bitcoin futures were down 2.4%, moving back below $40K. WTI crude settled down 0.5%.

    • Main focus on mixed earnings. After-hours highlighted by Netflix (NFLX) beat on subs growth. Markets bracing for upcoming reports from Magnificent Seven names. Aggregate beat rates off to a soft start, broadly in line with subdued expectations. Some talk of limited market upside amid rich valuations and moderating Fed rate cut expectations. Reports widely flagging Q4 GDP and PCE deflator as next checkpoints. Central bank attention turns to ECB meeting, though rates and guidance expected to remain unchanged.

    • Takeaways from China policy support were skeptical despite strength in local markets, particularly in Hong Kong. Reports Beijing considering mainland equity purchases of CNY2T ($278B) to stem market weakness seen only providing a short-term boost in the absence of meaningful reforms. Not much follow-through after the BOJ meeting. USD/JPY more than reversed notable strength during Governor Ueda's press conference. However, Nikkei futures lagged in US hours after yesterday's losses were attributed to positioning as BOJ appears to have moved one step closer to a rate hike with April still the main scenario.

    • Regional macro calendar marks the start of the monthly PMI cycle, starting with Japan. Recall Reuters Tankan showed manufacturing sentiment fell back while services continued to strengthen. Japan customs trade expected to show slower export growth reflecting softening global momentum mixed with pickup in imports. As expected, New Zealand Q4 CPI inflation eased to the weakest pace since mid-2021, though remained well above the RBNZ 1%~3% target range.

  • Pre-open Company News:

    • 532955.IN -- REC Ltd reports Q3 standalone EPS INR12.42 vs year-ago INR10.93 (14:15 IT)

    • 603127.CH -- JOINN Laboratories guides FY net income attributable CNY310.9-418.3M vs FactSet CNY567.2M [13 est, CNY199.6-719.5M]

    • 2246.HK -- Gogox holder Alibaba discloses sale of 1.8M shares on 18-Jan to reduce stake from 6.0% to 5.7%

    • 532432.IN -- United Spirits reports Q3 standalone EPS INR4.79 vs FactSet INR4.08 [6 est, INR3.80-4.40]

    • 6030.HK -- CITIC Securities reports preliminary FY net income attributable CNY19.69B vs FactSet CNY21.59B [20 est, CNY20.40-23.61B]

    • 1171.HK -- Yankuang Energy Group reports Q4 saleable coal production (ten kilotonnes) 3,489 vs year-ago 3,151

    • 500093.IN -- CG Power & Industrial Solutions reports Q3 consolidated EPS (cont ops) INR1.29 vs year-ago INR1.53 (14:39 IT)

    • 600372.CH -- China Avionics Systems guides FY net income attributable CNY1.76B vs year-ago restated CNY1.35B

    • 2138.HK -- EC Healthcare reports Q4 sales volume of no less than HK$1.10B, +7% y/y

    • 1138.HK -- COSCO SHIPPING Energy Transportation guides FY net income attributable CNY3.10-3.90B vs FactSet CNY5.00B [11 est, CNY4.09-6.44B]

    • 300413.CH -- Mango Excellent Media guides FY net income attributable CNY3.28-3.88B vs year-ago CNY1.86B

    • 603939.CH -- Yifeng Pharmacy Chain receives CSRC approval for proposed CNY1.80B convertible bond issuance

    • 688169.CH -- Beijing Roborock Technology guides FY net income attributable CNY2.00-2.20B vs FactSet CNY1.91B [21 est, CNY1.80-2.07B]

    • 500257.IN -- FDA grants tentative approval to Lupin's Rivaroxaban Tablets USP 2.5 mg, 10 mg, 15 mg, and 20 mg

    • DXP.VN -- Doan Xa Port reports Q4 net income VND24.22B vs year-ago VND4.92B

  • On Deck:

    • Hong Kong:

      • Earnings:

        • New Oriental Education & Technology Group (9901.HK), East Buy Holding (1797.HK), Vinda International Holdings (3331.HK)

    • Japan:

      • Economic:

        • 08:50 JST: Import NSA Y/Y (Preliminary); consensus (5.3%)

        • 08:50 JST: Trade Balance NSA (Preliminary); consensus (¥0.3T)

        • 08:50 JST: Export NSA Y/Y (Preliminary); consensus +9.2%

      • Earnings:

        • OBIC Co. (4684.JP), Nidec (6594.JP), DISCO Corp (6146.JP)

    • South Korea:

      • Earnings:

        • Kia (000270.KS), SK Hynix (000660.KS)

    • Australia:

      • Earnings:

        • Woodside Energy Group (WDS.AU)

    • India:

      • Earnings:

        • Exide Industries (500086.IN), Indian Oil Corp. (530965.IN), TVS Motor (532343.IN), Indian Overseas Bank (532388.IN), UCO Bank (532505.IN), Bajaj Auto (532977.IN), Tata Steel (500470.IN), Balkrishna Industries (502355.IN), Container Corp. of India (531344.IN), DLF Ltd (532868.IN)

    • Malaysia:

      • Economic:

        • 02:00 EST: BN Overnight Policy Rate; consensus +3%

    • Singapore:

      • Earnings:

        • Suntec Real Estate Investment Trust (T82U.SP), Mapletree Logistics Trust (M44U.SP)

  • Market Data:

    • Gold (Feb 24): +$3.40 or +0.17% to $2029.20

    • WTI Crude (Mar 24): +$0.17 or +0.23% to $74.54

    • $-¥: +0.17 or +0.11% to 148.2790

    • $-KRW: (2.23) or (0.17%) to 1337.2400

    • A$-$: +0.00 or +0.17% to 0.6583

    • $-INR: +0.10 or +0.12% to 83.2214

    • $-CNY: (0.05) or (0.68%) to 7.1453

  • If you would like to receive the Asian Market Preview daily, please search for Asia Pre-Market Updates in Alert Manager.

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE